+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endomyocardial Biopsy Market Size, Share & Trends Analysis Report By Product (Forceps, Accessories), By Tip (Straight, Maxi-curved, Pre-curved), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 5830964
Description Jump to:
The global endomyocardial biopsy market size is expected to reach USD 543.00 million by 2022, registering a CAGR of 6.8% from 2023 to 2030. The growth of the market is attributed to factors such as increasing prevalence of Cardiovascular Disorders (CVDs), rising demand for minimally invasive surgical procedures, and favorable reimbursement policies for coronary intervention procedures.

Increase in technological advancements and investment of multinational companies in the emerging economies serve as ideal opportunities for the growth and expansion of a market. There is a trend of healthcare reforms and advancements in technology for medical products and devices in the emerging economies. This creates an opportunity for manufacturers to introduce their products and capture a significant portion of the market. Countries like India, China and others are developing and are bringing about incremental changes to their healthcare systems providing enhanced treatment options to patients.

Furthermore, the availability of well-established healthcare infrastructure in developed countries enables easy accessibility to advanced diagnostic and treatment options. According to data published by the United Network for Organ Sharing, in 2022, over 4,111 heart transplants were performed in the U. S. As the number of heart transplants increases, the need for regular monitoring and early detection of rejection would also increase. This would further boost the demand for endomyocardial biopsy procedures.

The pandemic has highlighted the importance of regular monitoring and early detection of heart conditions among people which would further drive demand for the endomyocardial biopsy procedure in the coming years. Additionally, the adoption of remote monitoring technologies is expected to make endomyocardial biopsy procedures more accessible to patients, further supporting the growth of the market.

Endomyocardial Biopsy Market Report Highlights

  • Based on product, the forceps segment captured the highest market share in 2022 owing to the development of new and improved forceps with better grip and precision
  • Based on tip, the straight tip segment dominated the market in 2022, as the usage of straight tip minimizes the risk of tissue damage during the biopsy, ensuring that the collected tissue is suitable for accurate diagnosis
  • Based on end-use, the hospitals segment is expected to dominate the market in 2022. Owing to factors such as increasing number hospitals globally coupled with increasing volume of biopsy procedures
  • North America dominated the endomyocardial biopsy market and accounted for the largest revenue share of 44.5% in 2022 owing to the increasing number of geriatric population and well-developed healthcare infrastructure


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Tip
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. Tip Outlook
2.2.3. End-use Outlook
2.2.4. Regional Outlook
2.3. Competitive Insights
Chapter 3. Endomyocardial Biopsy Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Industry Value Chain Analysis
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing prevalence of cardiovascular disorders (CVDs)
3.3.1.2. Untapped opportunities in developing economies.
3.3.1.3. Rising demand for minimally invasive surgical procedures
3.3.1.4. Favorable reimbursement policies for coronary intervention procedures
3.3.2. Market restraint analysis
3.3.2.1. Complications associated with endomyocardial biopsy
3.3.2.2. Lack of skilled professionals
3.3.3. Market opportunity analysis
3.3.3.1. Improvement in healthcare infrastructure in developing economies
3.4. Endomyocardial Biopsy Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.4. Market Entry Strategies
Chapter 4. Endomyocardial Biopsy Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Forceps
4.1.2. Accessories
4.2. Product Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Endomyocardial Biopsy Market by Product Outlook
4.5. Market Application & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Forceps
4.5.1.1. Market estimates and forecast 2018 - 2030 (Revenue in USD Million)
4.5.2. Accessories
4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 5. Endomyocardial Biopsy: Tip Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Maxi-curved
5.1.2. Straight
5.1.3. Pre-curved
5.1.4. Others
5.2. Tip Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Global Endomyocardial Biopsy Market by Tip Outlook
5.5. Market Application & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Maxi-curved
5.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
5.5.1.2. Straight
5.5.1.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
5.5.1.3. Pre-curved
5.5.1.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
5.5.1.4. Others
5.5.1.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 6. Endomyocardial Biopsy: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Ambulatory surgical centers
6.1.3. Others
6.2. End-use Market Share, 2022 & 2030
6.3. Segment Dashboard
6.4. Global Endomyocardial Biopsy Market by End-use Outlook
6.5. Market Application & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
6.5.2. Ambulatory surgical centers
6.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
6.5.3. Others
6.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 7. Endomyocardial Biopsy Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2022
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
7.6. North America
7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
7.6.2. U.S.
7.6.2.1. Key country dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement scenario
7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
7.6.3. Canada
7.6.3.1. Key country dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement scenario
7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
7.7. Europe
7.7.1. UK
7.7.1.1. Key country dynamics
7.7.1.2. Competitive Scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement scenario
7.7.1.5. UK market estimates and forecasts, 2018 - 2030
7.7.2. Germany
7.7.2.1. Key country dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
7.7.3. France
7.7.3.1. Key country dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement scenario
7.7.3.5. France market estimates and forecasts, 2018 - 2030
7.7.4. Italy
7.7.4.1. Key country dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement scenario
7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
7.7.5. Spain
7.7.5.1. Key country dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement scenario
7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
7.7.6. Denmark
7.7.6.1. Key country dynamics
7.7.6.2. Competitive Scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement scenario
7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
7.7.7. Sweden
7.7.7.1. Key country dynamics
7.7.7.2. Competitive Scenario
7.7.7.3. Regulatory framework
7.7.7.4. Reimbursement scenario
7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
7.7.8. Norway
7.7.8.1. Key country dynamics
7.7.8.2. Competitive Scenario
7.7.8.3. Regulatory framework
7.7.8.4. Reimbursement scenario
7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
7.8. Asia Pacific
7.8.1. Japan
7.8.1.1. Key country dynamics
7.8.1.2. Competitive Scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement scenario
7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
7.8.2. India
7.8.2.1. Key country dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement scenario
7.8.2.5. India market estimates and forecasts, 2018 - 2030
7.8.3. China
7.8.3.1. Key country dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory framework
7.8.3.4. Reimbursement scenario
7.8.3.5. China market estimates and forecasts, 2018 - 2030
7.8.4. South Korea
7.8.4.1. Key country dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory framework
7.8.4.4. Reimbursement scenario
7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
7.8.5. Australia
7.8.5.1. Key country dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory framework
7.8.5.4. Reimbursement scenario
7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
7.8.6. Thailand
7.8.6.1. Key country dynamics
7.8.6.2. Competitive Scenario
7.8.6.3. Regulatory framework
7.8.6.4. Reimbursement scenario
7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
7.9. Latin America
7.9.1. Brazil
7.9.1.1. Key country dynamics
7.9.1.2. Competitive Scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement scenario
7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
7.9.2. Mexico
7.9.2.1. Key country dynamics
7.9.2.2. Competitive Scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement scenario
7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
7.9.3. Argentina
7.9.3.1. Key country dynamics
7.9.3.2. Competitive Scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement scenario
7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
7.10. MEA
7.10.1. South Africa
7.10.1.1. Key country dynamics
7.10.1.2. Competitive Scenario
7.10.1.3. Regulatory framework
7.10.1.4. Reimbursement scenario
7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
7.10.2. Saudi Arabia
7.10.2.1. Key country dynamics
7.10.2.2. Competitive Scenario
7.10.2.3. Regulatory framework
7.10.2.4. Reimbursement scenario
7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
7.10.3. UAE
7.10.3.1. Key country dynamics
7.10.3.2. Competitive Scenario
7.10.3.3. Regulatory framework
7.10.3.4. Reimbursement scenario
7.10.3.5. UAE market estimates and forecasts, 2018 - 2030
7.10.4. Kuwait
7.10.4.1. Key country dynamics
7.10.4.2. Competitive Scenario
7.10.4.3. Regulatory framework
7.10.4.4. Reimbursement scenario
7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.2.2. Market Leaders
8.2.3. Emerging Players
8.3. Vendor Landscape
8.3.1. Argon Medica Devices, Inc.
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Cordis
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Mermaid Medical
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Terumo Corporation
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Scholten Surgical Instruments, Inc.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Changzhou Lookmed Medical Instrument Co., Ltd.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.7. Strategic initiatives
8.3.8. Fehling Instruments
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America endomyocardial biopsy market, by region, 2018 - 2030 (USD Million)
Table 3 North America endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 4 North America endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 5 North America endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 8 U.S. endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 10 Canada endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 11 Canada endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 12 Europe endomyocardial biopsy market, by region, 2018 - 2030 (USD Million)
Table 13 Europe endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 14 Europe endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 15 Europe endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 16 U.K. endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 17 U.K. endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 18 U.K. endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 19 Germany endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 20 Germany endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 21 Germany endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 22 France endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 23 France endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 24 France endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 25 Italy endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 26 Italy endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 27 Italy endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 28 Spain endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 29 Spain endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 30 Spain endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 31 Denmark endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 32 Denmark endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 33 Denmark endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 34 Sweden endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 35 Sweden endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 36 Sweden endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 37 Norway endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 38 Norway endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 39 Norway endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 40 APAC endomyocardial biopsy market, by region, 2018 - 2030 (USD Million)
Table 41 APAC endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 42 APAC endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 43 APAC endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 44 China endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 45 China endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 46 China endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 47 Japan endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 48 Japan endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 49 Japan endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 50 India endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 51 India endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 52 India endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 53 Australia endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 54 Australia endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 55 Australia endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 56 South Korea endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 57 South Korea endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 58 South Korea endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 59 Thailand endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 60 Thailand endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 61 Thailand endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 62 Latin America endomyocardial biopsy market, by region, 2018 - 2030 (USD Million)
Table 63 Latin America endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 64 Latin America endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 65 Latin America endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 66 Brazil endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 67 Brazil endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 68 Brazil endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 69 Mexico endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 70 Mexico endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 71 Mexico endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 72 Argentina endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 73 Argentina endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 74 Argentina endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa endomyocardial biopsy market, by region, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 79 South Africa endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 80 South Africa endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 81 South Africa endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 85 UAE endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 86 UAE endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 87 UAE endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
Table 88 Kuwait endomyocardial biopsy market, by product, 2018 - 2030 (USD Million)
Table 89 Kuwait endomyocardial biopsy market, by tip, 2018 - 2030 (USD Million)
Table 90 Kuwait endomyocardial biopsy market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Endomyocardial biopsy market: market outlook
Fig. 14 Endomyocardial biopsy market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook.
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Endomyocardial biopsy market driver impact
Fig. 20 Endomyocardial biopsy market restraint impact
Fig. 21 Endomyocardial biopsy market strategic initiatives analysis
Fig. 22 Endomyocardial biopsy market: product movement analysis
Fig. 23 Endomyocardial biopsy market: product outlook and key takeaways
Fig. 24 Forceps market estimates and forecast, 2018 - 2030
Fig. 25 Accessories market estimates and forecast, 2018 - 2030
Fig. 26 Endomyocardial biopsy market: tip movement analysis
Fig. 27 Endomyocardial biopsy market: tip outlook and key takeaways
Fig. 28 Maxi-curved market estimates and forecast, 2018 - 2030
Fig. 29 Straight market estimates and forecast, 2018 - 2030
Fig. 30 Pre-curved market estimates and forecast, 2018 - 2030
Fig. 31 Others market estimates and forecast, 2018 - 2030
Fig. 32 Endomyocardial biopsy market: end use movement analysis
Fig. 33 Endomyocardial biopsy market: end use outlook and key takeaways
Fig. 34 Hospitals market estimates and forecast, 2018 - 2030
Fig. 35 Ambulatory surgical centers market estimates and forecast, 2018 - 2030
Fig. 36 Others market estimates and forecast, 2018 - 2030
Fig. 37 Global endomyocardial biopsy market: regional movement analysis
Fig. 38 Global endomyocardial biopsy market: regional outlook and key takeaways
Fig. 39 Global market shares and leading players
Fig. 40 North America market share and leading players
Fig. 41 Europe market share and leading players
Fig. 42 Asia Pacific market share and leading players
Fig. 43 Latin America market share and leading players
Fig. 44 Middle East & Africa market share and leading players
Fig. 45 North America, by country
Fig. 46 North America
Fig. 47 North America market estimates and forecast, 2018 - 2030
Fig. 48 U.S.
Fig. 49 U.S. market estimates and forecast, 2018 - 2030
Fig. 50 Canada
Fig. 51 Canada market estimates and forecast, 2018 - 2030
Fig. 52 Europe
Fig. 53 Europe market estimates and forecast, 2018 - 2030
Fig. 54 U.K.
Fig. 55 U.K. market estimates and forecast, 2018 - 2030
Fig. 56 Germany
Fig. 57 Germany market estimates and forecast, 2018 - 2030
Fig. 58 France
Fig. 59 France market estimates and forecast, 2018 - 2030
Fig. 60 Italy
Fig. 61 Italy market estimates and forecast, 2018 - 2030
Fig. 62 Spain
Fig. 63 Spain market estimates and forecast, 2018 - 2030
Fig. 64 Denmark
Fig. 65 Denmark market estimates and forecast, 2018 - 2030
Fig. 66 Sweden
Fig. 67 Sweden market estimates and forecast, 2018 - 2030
Fig. 68 Norway
Fig. 69 Norway market estimates and forecast, 2018 - 2030
Fig. 70 Asia Pacific
Fig. 71 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 72 China
Fig. 73 China market estimates and forecast, 2018 - 2030
Fig. 74 Japan
Fig. 75 Japan market estimates and forecast, 2018 - 2030
Fig. 76 India
Fig. 77 India market estimates and forecast, 2018 - 2030
Fig. 78 Australia
Fig. 79 Australia market estimates and forecast, 2018 - 2030
Fig. 80 South Korea
Fig. 81 South Korea market estimates and forecast, 2018 - 2030
Fig. 82 Thailand
Fig. 83 Thailand market estimates and forecast, 2018 - 2030
Fig. 84 Latin America
Fig. 85 Latin America market estimates and forecast, 2018 - 2030
Fig. 86 Brazil
Fig. 87 Brazil market estimates and forecast, 2018 - 2030
Fig. 88 Mexico
Fig. 89 Mexico market estimates and forecast, 2018 - 2030
Fig. 90 Argentina
Fig. 91 Argentina market estimates and forecast, 2018 - 2030
Fig. 92 Middle East and Africa
Fig. 93 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 94 Saudi Arabia
Fig. 95 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 96 South Africa
Fig. 97 South Africa market estimates and forecast, 2018 - 2030
Fig. 98 UAE
Fig. 99 UAE market estimates and forecast, 2018 - 2030
Fig. 100 Kuwait
Fig. 101 Kuwait market estimates and forecast, 2018 - 2030
Fig. 102 Participant categorization- Endomyocardial biopsy market
Fig. 103 Market share of key market players- Endomyocardial biopsy market

Companies Mentioned

  • Argon Medica Devices, Inc.
  • Cordis
  • Mermaid Medical
  • Terumo Corporation
  • Scholten Surgical Instruments, Inc.
  • Changzhou Lookmed Medical Instrument Co., Ltd.
  • Fehling Instruments

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 321.55 Million
Forecasted Market Value ( USD ) by 2030 $ 543 Million
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned7

Related Topics

Related Reports

Cancer Biopsy Market Size, Share & Trends Analysis Report By Type (Liquid Biopsy, Core Needle Biopsy), By Application (Breast Cancer, Lung Cancer), By Product (Kits & Consumables, Instruments), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Cancer Biopsy Market Size, Share & Trends Analysis Report By Type (Liquid Biopsy, Core Needle Biopsy), By Application (Breast Cancer, Lung Cancer), By Product (Kits & Consumables, Instruments), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 140 Pages
  • Global
From
Fusion Biopsy Market Size, Share & Trends Analysis Report By Biopsy Route (Transrectal, Transperineal), By End-use (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Fusion Biopsy Market Size, Share & Trends Analysis Report By Biopsy Route (Transrectal, Transperineal), By End-use (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 100 Pages
  • Global
From
Global Cancer Biopsy Market by Product (Instruments, Kits & Consumables, Services), Type (Liquid Biopsies, Tissue Biopsies), Indication - Forecast 2024-2030 - Product Image

Global Cancer Biopsy Market by Product (Instruments, Kits & Consumables, Services), Type (Liquid Biopsies, Tissue Biopsies), Indication - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Global Breast Biopsy Market by Product (Assay Kits, Biopsy Needles, Biopsy Tables), Type (Liquid Breast Biopsy, Needle Breast Biopsy, Open Surgical Breast Biopsy), Guidance, Application - Forecast 2024-2030 - Product Image

Global Breast Biopsy Market by Product (Assay Kits, Biopsy Needles, Biopsy Tables), Type (Liquid Breast Biopsy, Needle Breast Biopsy, Open Surgical Breast Biopsy), Guidance, Application - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Breast Biopsy Devices Market by Type (Needles, Tables, Assay Kits, Liquid Biopsy), Procedure (CNB, FNAB, VAB, Surgical), Technique (Stereotactic, USG, MRI), Application (Screening, Treatment), End User (Hospitals, Clinic) & Region - Global Forecast to 2028 - Product Image

Breast Biopsy Devices Market by Type (Needles, Tables, Assay Kits, Liquid Biopsy), Procedure (CNB, FNAB, VAB, Surgical), Technique (Stereotactic, USG, MRI), Application (Screening, Treatment), End User (Hospitals, Clinic) & Region - Global Forecast to 2028

  • Report
  • 260 Pages
  • Global
From

About the Endomyocardial Biopsy Market

The Endomyocardial Biopsy (EMB) market is a subset of the larger Surgical Procedures market. It is a minimally invasive procedure used to diagnose and monitor heart conditions. During the procedure, a small sample of tissue is taken from the heart muscle and examined for signs of disease. The procedure is typically performed in a hospital or clinic setting, and is usually done under general anesthesia. The EMB market is driven by the increasing prevalence of cardiovascular diseases, as well as the need for accurate diagnosis and monitoring of these conditions. Technological advancements in the field have also contributed to the growth of the market, as they have enabled more accurate and efficient diagnosis. Some of the major players in the EMB market include Medtronic, St. Jude Medical, Boston Scientific, and Abbott Laboratories. These companies offer a range of products and services related to EMB, including catheters, guidewires, and other medical devices. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.